Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TryCort: Oral Prednisolone Test for Rheumatoid Arthritis
NCT01395251Phase 3Completed
- Sponsor
- Rheumazentrum Ruhrgebiet
- Start
- Feb 2012
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of prednisolone in rheumatoid arthritis (RA), sponsored by Rheumazentrum Ruhrgebiet. Primary endpoints: Rate of true diagnosis of rheumatoid arthritis after positive prednisolone test at 3 months, Rate of true negative diagnosis of rheumatoid arthritis after positive prednisolone test at 3 months and 2 more. Started Feb 2012; status: completed.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01395251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395251.